Opioid use disorder (OUD) remains a significant public health crisis, with over 5 million people diagnosed in the U.S. in 2023 and more than 80,000 fatal overdoses involving opioids each year. Current FDA-approved medications for OUD target the micro-opioid receptor, but these treatments are still associated with high relapse rates during abstinence.